Infinity Pharmaceuticals Inc.
NASDAQ:INFI
| Market Cap (Intraday) | 166.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.12 |
| 50-Day MA | $2.64 |
| 200-Day MA | $3.00 |
Infinity Pharmaceuticals Inc. Stock, NASDAQ:INFI
1100 Massachusetts Avenue, 4th floor, Cambridge, Massachusetts 02138
United States of America
Phone: +1.617.453.1000
Number of Employees: 23
Description
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.